NFKB1 and breast carcinoma: Our results align with breast cancer study59 and colorectal cancer study60 that have found CEMIP expression to be regulated by NF‐κB and AP‐1‐binding sites within its promoter region, indicating that the interplay between genetic and epigenetic mechanisms is crucial for its gene expression.